secwatch / observer

8-K filed May 28, 2026, 6:26 PM ET ticker AGNC CIK 0001423689

other material confidence high sentiment neutral materiality 0.60

AGNC launches up to $2B at-the-market common stock issuance program

AGNC Investment Corp.

Program allows AGNC to sell up to $2 billion of common stock through 14 agents on a best-efforts basis.
Sales may be made on Nasdaq, OTC, block trades, or privately negotiated deals.
Agent compensation up to 1.0% of gross sales price for shares sold.
Program terminates upon sale of all shares or termination of agreements by AGNC or any agent.
Shares issued under existing shelf registration statement and prospectus supplement dated May 28, 2026.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001423689-26-000121
form_type: 8-K
ticker: AGNC
cik: 0001423689
company_name: AGNC Investment Corp.
filed_at: 2026-05-28T22:26:40+00:00
discovered_at: 2026-05-29T10:05:01.334874+00:00
generated_at: 2026-05-29T10:06:51.394130+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001423689-26-000121
json_url: https://secwatch.observer/filing/0001423689-26-000121.json
markdown_url: https://secwatch.observer/filing/0001423689-26-000121.md
text_url: https://secwatch.observer/filing/0001423689-26-000121.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1423689/000142368926000121/0001423689-26-000121-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1423689/000142368926000121/agnc-20260528.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

SYRE

Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030

Spyre Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ORKA

Oruka Therapeutics expands ORKA-001 license to include IBD; clinical dosing restrictions until 2028-2030

Oruka Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Via Renewables to redeem all 1,884,935 shares of its 8.75% Series A Preferred at $25.00 per share plus dividends

Via Renewables, Inc. June 1, 2026, 3:06 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BUKS

CEO Christopher Reedy discloses ongoing cancer treatment; remains in role

BUTLER NATIONAL CORP June 1, 2026, 12:41 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ONCY

Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned

ONCOLYTICS BIOTECH INC June 1, 2026, 9:06 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CLIR

ClearSign Technologies prices 777,780-share public offering at $4.33/share for ~$3.37M gross proceeds

ClearSign Technologies Corp June 1, 2026, 8:30 AM ET other_material Items 1.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001423689-26-000121

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.